Tag: aerpio pharmaceuticals
March 16, 2020
Aerpio Reports Q4 and Full Year 2019 Financial Results
Aerpio Pharmaceuticals reported financial results for the fourth quarter and full year ended December 31, 2019.
January 27, 2019
5 Top Weekly NASDAQ Biotech Stocks: Synergy on Top
Synergy Pharmaceuticals, Alpine Immune Sciences, Aerpio Pharmaceuticals, Correvio Pharma and Athersys were last week's top gainers. June 26, 2018
Aerpio Pharmaceuticals Announces Uplisting to Nasdaq Capital Market and Pricing of $45.0 Million Public Offering of Common Stock
Aerpio Pharmaceuticals (OTCQB:ARPO) announced that its common stock will begin trading on the Nasdaq Capital Market under the symbol “ARPO”...
June 25, 2018
Aerpio and Gossamer Bio Announce License Agreement
The agreement could bring sales milestones of Aerpio up to US$400 million, including US$20 million as an upfront payment, potential... June 25, 2018